Sheng, X., Zhang, C., Ji, Y., Zhou, L., Zou, B., Huang, H., Wang, Y., Yang, K., Bai, X., Feng, D., Yang, Y., Bian, J., Yu, Z., Niu, H., Du, P., Fang, J., He, Z., Guo, J. (2025). Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.665